6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile
C23H19F3N6 — CID 153127953
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile
6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile (PubChem CID 153127953) has the molecular formula C23H19F3N6 and a molecular weight of 436.44 g/mol. Its IUPAC name is 6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 153127953 |
| Molecular Formula | C23H19F3N6 |
| Molecular Weight | 436.44 g/mol |
| Exact Mass | 436.16 |
| IUPAC Name | 6-[5-butyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridinyl]pyridine-3-carbonitrile |
| SMILES | CCCCc1cc(-c2ccc(C#N)cn2)cnc1-c1nc2cc(C(F)(F)F)cnc2n1C |
| InChI | InChI=1S/C23H19F3N6/c1-3-4-5-15-8-16(18-7-6-14(10-27)11-28-18)12-29-20(15)22-31-19-9-17(23(24,25)26)13-30-21(19)32(22)2/h6-9,11-13H,3-5H2,1-2H3 |
| InChIKey | VWDREGXIFHNKOP-UHFFFAOYSA-N |
| XLogP | 5.33 |
| TPSA | 80.28 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.44 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153127953 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.